1-benzyl-4-((4-bromophenyl)amino)piperidine-4-carbonitrile | 1395493-20-5

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 英文名称: 1-benzyl-4-((4-bromophenyl)amino)piperidine-4-carbonitrile
• 英文别名: 1-benzyl-4-(4-bromoanilino)piperidine-4-carbonitrile
• CAS: 1395493-20-5
• 化学式: C₁₉H₂₀BrN₃
• 分子量: 370.292
• InChiKey: MGCGEPFSAYSXOO-UHFFFAOYSA-N

物化性质

• 沸点：
  508.1±50.0 °C(Predicted)
• 密度：
  1.38±0.1 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  4.3
• 重原子数：
  23
• 可旋转键数：
  4
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.32
• 拓扑面积：
  39.1
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  1-benzyl-4-((4-bromophenyl)amino)piperidine-4-carbonitrile 在 硫酸 、 ammonium hydroxide 作用下， 以 水 为溶剂， 生成 1-benzyl-4-(4-bromophenylamino)piperidine-4-carboxamide
  参考文献：
  名称：

  Design, Synthesis, and Biological Evaluation of Halogenated N-(2-(4-Oxo-1-phenyl-1,3,8-triazaspiro[4.5]decan-8-yl)ethyl)benzamides: Discovery of an Isoform-Selective Small Molecule Phospholipase D2 Inhibitor

  摘要：

  Phospholipase D (PLD) catalyzes the conversion of phosphatidylcholine to the lipid second messenger phosphatidic acid. Two mammalian isoforms of PLD have been identified, PLD I and PLD2, which share 53% sequence identity and are subject to different regulatory mechanisms. Inhibition of PLD enzymatic activity leads to increased cancer cell apoptosis, decreased cancer cell invasion, and decreased metastasis of cancer cells; therefore, the development of isoform-specific, PLD inhibitors is a novel approach for the treatment of cancer. Previously, we developed potent dual PLD1/PLD2, PLD1-specific (> 1700-fold selective), and moderately PLD2-preferring (> 10-fold preferring) inhibitors. Here, we describe a matrix library strategy that afforded the most potent (PLD2 IC(50) = 20 nM) and selective (75-fold selective versus PLD1) PLD2 inhibitor to date. N-(2-(1-(3-fluorophenyl)-4-oxo-1.3.8-triazaspiro[4.5]decan-8-yl)ethyl)-2-naphthamide (22a), with an acceptable DMPK profile. Thus, these new isoform-selective PLD inhibitors will enable researchers to dissect the signaling roles and therapeutic potential of individual PLD isoforms to an unprecedented degree.

  DOI：

  10.1021/jm100814g
• 作为产物：
  描述：

  N-苄基哌啶酮 、 4-溴苯胺 、 氰化钾 生成 1-benzyl-4-((4-bromophenyl)amino)piperidine-4-carbonitrile
  参考文献：
  名称：

  TSUDA, NOBUNAO;ARITA, MASAFUMI;XAMADZAKI, TOSIO

  摘要：

  DOI：

文献信息

• [EN] TRPA1 MODULATORS<br/>[FR] MODULATEURS DE TRPA1
  申请人：ALGOMEDIX INC

  公开号：WO2015103060A1

  公开（公告）日：2015-07-09

  This disclosure relates to polycyclic heteroaromatic compounds useful as TRPA1 modulators, as well as compositions and methods of treating pain that include the compounds.

  这份披露涉及到多环杂芳化合物，这些化合物可用作TRPA1调节剂，以及包括这些化合物的用于治疗疼痛的组合物和方法。
• TRPA1 MODULATORS
  申请人：Algomedix, Inc.

  公开号：EP3092228A1

  公开（公告）日：2016-11-16